The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities
Globally, prostate cancer (PCa) is regarded as a challenging health issue, and the number
of PCa patients continues to rise despite the availability of effective treatments in recent …
of PCa patients continues to rise despite the availability of effective treatments in recent …
Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review
Several signaling pathways and basic metabolites are responsible for the control of
metabolism in both normal and cancer cells. As emerging hallmarks of cancer metabolism …
metabolism in both normal and cancer cells. As emerging hallmarks of cancer metabolism …
Baicalein as promising anticancer agent: A comprehensive analysis on molecular mechanisms and therapeutic perspectives
AKMH Morshed, S Paul, A Hossain, T Basak… - Cancers, 2023 - mdpi.com
Simple Summary Cancer is a multifactorial disease characterized by excessive cell
proliferation in a specific organ. The most common treatments include chemotherapy …
proliferation in a specific organ. The most common treatments include chemotherapy …
The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism
Cancer cells underlie the dysregulated metabolism of carbohydrate, lipid and protein and
thereby, employ interconnected cross-linked signaling pathways to supply adequate energy …
thereby, employ interconnected cross-linked signaling pathways to supply adequate energy …
E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9
Previously, our laboratory demonstrated that a deregulated E2F5/p38/SMAD3 axis was
associated with uncontrolled cellular proliferation in prostate cancer (PCa). Here, we …
associated with uncontrolled cellular proliferation in prostate cancer (PCa). Here, we …
Ophiopogonin D′, a Natural Product From Radix Ophiopogonis, Induces in Vitro and in Vivo RIPK1-Dependent and Caspase-Independent Apoptotic Death in …
Z Lu, H Wang, M Zhu, W Song, J Wang, C Wu… - Frontiers in …, 2018 - frontiersin.org
Objective: The purpose of this study was to evaluate the anticancer effects of Ophiopogonin
D′(OPD′, a natural product extracted from a traditional Chinese medicine (Radix …
D′(OPD′, a natural product extracted from a traditional Chinese medicine (Radix …
Therapeutic potentials of natural compounds acting on cyclic nucleotide phosphodiesterase families
A Abusnina, C Lugnier - Cellular signalling, 2017 - Elsevier
Intracellular cyclic AMP and/or cyclic GMP are characterized in the 1960th. These second
messengers, hydrolysed specifically by cyclic nucleotide phosphodiesterase (PDE), play a …
messengers, hydrolysed specifically by cyclic nucleotide phosphodiesterase (PDE), play a …
Glycyrrhiza glabra-Enhanced Extract and Adriamycin Antiproliferative Effect on PC-3 Prostate Cancer Cells
K Gioti, A Papachristodoulou, D Benaki… - Nutrition and …, 2020 - Taylor & Francis
Prostate cancer is the second most commonly diagnosed cancer in men worldwide, which is
almost incurable, once it progresses into the metastatic stage. Adriamycin (ADR) is a known …
almost incurable, once it progresses into the metastatic stage. Adriamycin (ADR) is a known …
[HTML][HTML] Prostate cancer: therapeutic prospect with herbal medicine
Prostate cancer (PCa) is a major cause of morbidity and mortality in men worldwide. A
geographic variation on the burden of the disease suggested that the environment, genetic …
geographic variation on the burden of the disease suggested that the environment, genetic …
[HTML][HTML] Anti-tumor activities of Panax quinquefolius saponins and potential biomarkers in prostate cancer
S He, F Lyu, L Lou, L Liu, S Li, J Jakowitsch… - Journal of ginseng …, 2021 - Elsevier
Background Prostate carcinoma is the second most common cancer among men worldwide.
Developing new therapeutic approaches and diagnostic biomarkers for prostate cancer (PC) …
Developing new therapeutic approaches and diagnostic biomarkers for prostate cancer (PC) …